STAT+: Lilly is a holdout among companies that agree to disclose when executive pay is clawed back
A coalition of institutional investors is pushing Eli Lilly to adopt a policy to disclose…
Category: Pharmalot
STAT+: Pharmalittle: U.S. puts J&J in charge of plant that botched Covid-19 vaccines; pharmacies offering Covid shots raise privacy concerns
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Bristol Myers agrees to pay $75 million to settle allegations of underpaying Medicaid rebates
After years of litigation, Bristol-Myers Squibb (BMY) agreed to pay $75 million, plus interest, to…
STAT+: Pharmalittle: FDA is probing J&J Covid-19 vaccine blunder; Fauci says U.S. may not need the AstraZeneca shot
And so, another working week will soon draw to a close. Not a moment too…
STAT+: FDA is rebuked by a federal agency for downgrading serious concerns over plant inspections
In a stern letter, the U.S. Office of Special Counsel rebuked the Food and Drug…
STAT+: Pharmalittle: 15 million doses of J&J Covid-19 vaccine ruined by ‘human error’; Bristol Myers fights U.S. over a $1.4 billion tax bill
Top of the morning to you. A spot of rain is descending on the Pharmalot…
STAT+: The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research
American taxpayers may have provided $162 million toward researching the drug remdesivir, but the federal…
STAT+: Pharmalittle: Pfizer says Covid-19 shot is safe and effective in adolescents; FTC wants to block another Illumina deal
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: FTC seeks to block Illumina from buying Grail, citing threats to competition
The Federal Trade Commission is once again trying to block Illumina, a dominant maker of…
STAT+: Most U.S. universities get an ‘F’ on ensuring access to drugs they discover
Despite large amounts of taxpayer funding, dozens of the largest U.S. universities failed to commit…
STAT+: Pharmalittle: Pfizer and BioNTech to boost Covid-19 vaccine production; lawmakers ask FTC to probe insulin pricing
Rise and shine, another busy day is on the way. There is a rhythm to…
STAT+: Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries
Twice in recent months, a small Canadian company has approached two large drug makers to…
STAT+: Congressional lawmakers urge FTC to investigate insulin makers over their pricing
In the latest flare up over the cost of insulin, several Congressional lawmakers want the…
STAT+: Pharmalittle: White House eyes suspending patent rights on Covid-19 vaccines; J&J supplier may be a vaccine bottleneck
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment
A former top lobbyist at Eli Lilly (LLY) has filed a lawsuit accusing an executive…
STAT+: Canada says drug spending keeps rising due to increasingly expensive specialty meds
As Canadians brace for new rules to address prescription drug spending, a government report found…
STAT+: Pharmalittle: Novavax faces raw-materials shortages for Covid-19 shot; India curbs vaccine exports
And so, another working week will soon draw to a close. Not a moment too…
STAT+: With time running out, an ALS patient fights with Biogen over expanded access to its drug
Earlier this year, Lisa Stockman Mauriello was diagnosed with a fast-moving form of ALS, a…
STAT+: EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance
Amid rising concern over antibiotic resistance, a coalition of advocacy groups has filed a lawsuit…
HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access
Seeking to quickly widen global access to Covid-19 vaccines, academics, and patient advocates are urging…
STAT+: Pharmalittle: AstraZeneca revises Covid-19 vaccine effectiveness; contractors grab a big slice of vaccine revenues
Good morning, everyone, and how are you today? The sun is trying to peek through…
STAT+: Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history
For more than a decade, Pfizer has run dozens of trials in hopes of eventually…
Universities launch opioid litigation archive to ‘ensure history doesn’t repeat itself’
After two decades in which opioid overdoses claimed more than 400,000 lives in the U.S.,…
STAT+: Pharmalittle: Europe moves to curb Covid-19 vaccine exports; Slaoui fired from Galvani board over sexual harassment claim
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: AbbVie accuses a company of recruiting an employee in order to steal Humira secrets
Two years ago, a manufacturing team leader at AbbVie (ABBV) took a similar job at…
STAT+: Pharmalittle: AstraZeneca may have used ‘outdated’ info about its Covid-19 shot; Democrats eye drug-pricing measures
Rise and shine, everyone, another busy day is on the way. We can tell by…
STAT+: Lawmakers introduce a bill to prevent Sacklers from using bankruptcy ‘loophole’ to evade liability
In a move directed at the owners of Purdue Pharma, a pair of Democratic lawmakers…
STAT+: Pharmalittle: AstraZeneca says studies show its Covid-19 vaccine is 79% effective; rich countries created vaccine inequity
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
‘The public is being denied the truth’: A legal expert blasts Purdue’s bankruptcy plan to end opioid lawsuits
Earlier this week, Purdue Pharma filed a bankruptcy plan that would have some members of…
STAT+: Pharmalittle: Some European countries to resume use of AstraZeneca Covid-19 shot; Senate confirms Becerra as HHS secretary
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Does a drug’s name affect how patients and doctors perceive it? The FDA wants to know
Drug makers may spend untold sums of money giving medicines zippy names. Now, regulators want…
STAT+: Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed
Amid increasing concern over antibiotic resistance, a new analysis found that nearly 56% of the…
STAT+: AmerisourceBergen say-on-pay proposal squeaks by amid outrage over CEO compensation
In a rebuke to AmerisourceBergen (ABC), nearly half of its shareholders voted against a “say-on-pay”…
STAT+: Pharmalittle: Europe isn’t ruling out waiving IP rights for Covid-19 shots; AstraZeneca defends vaccine production process
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Pharma wins a round in a battle with HHS over a drug discount program for hospitals
In a victory for the pharmaceutical industry, a federal judge temporarily blocked the federal government…
STAT+: Pharmalittle: Pfizer looks to raise price of Covid-19 shot after pandemic ends; FTC will be tougher on pharma mergers
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Washington may become the second state to distribute its own generic drugs
A bill moving through the Washington legislature may make the state only the second in…
STAT+: Pharma mergers face fresh scrutiny by a new international antitrust group
In response to a spate of pharmaceutical mergers, several antitrust regulators and enforcement agencies from…
STAT+: Pharmalittle: More countries halt use of AstraZeneca Covid-19 vaccine; Moderna studies its shot in children
Rise and shine, another busy day is on the way. Most days are busy, though,…
Sacklers boost Purdue Pharma settlement to $4.3 billion in plan that would end their control of the opioid maker
In a move that could spell the end of Purdue Pharma, the company has filed…
STAT+: Once again, the viability of the U.S. biosimilar market is thrown into question
Despite periodic reports that biosimilars have finally arrived and will save the U.S. health care…
STAT+: Pharmalittle: Covid-19 vaccine shortages prompt new manufacturing alliances; WHO endorses AstraZeneca shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: U.S. sits on millions of AstraZeneca vaccine doses; WTO again fails to act on Covid-19 proposal
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Ohio attorney general sues a health plan over its PBM contracts and Medicaid costs
In the latest bid to pull back the curtain on pharmacy benefit managers, the Ohio…
STAT+: Medicare spending on neurology drugs jumped, while number of claims barely budged
During a recent five-year period, Medicare spending on hundreds of medicines to treat various neurologic…
STAT+: Pharmalittle: Lilly fired manager who tracked employee production complaints; Denmark suspends AstraZeneca shot
Top of the morning to you, and a fine one it is. We say this…
STAT+: Antibiotic prescribing during the pandemic raises concern about drug resistance
Amid rising worries over antibiotic resistance, a new study suggests the drugs were overprescribed to…
STAT+: Pharmalittle: Biden urged by former FDA commissioners to pick agency chief; Lilly reports more positive data for Covid-19 drug
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal
Rise and shine, another busy day is on the way. We can tell it is…
STAT+: Drug makers urge Biden to reject proposal to waive patent rights on Covid-19 products
More than two dozen of the largest pharmaceutical companies are urging President Biden to reject…